Physician profile
Robin Abraham
NPI 1093497240
$1,344.15
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,283 · Education: $60.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,283.16 |
| Education | $60.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $406.81 | 2024 | Caplyta |
| Abbvie INC. | $322.56 | 2024 | |
| Corium, LLC | $127.55 | 2024 | Azstarys |
| Teva Pharmaceuticals USA, INC. | $112.66 | 2024 | Austedo Xr, Uzedy |
| Neurocrine Biosciences, INC. | $109.55 | 2024 | Ingrezza |
| Axsome Therapeutics, INC. | $105.62 | 2024 | Sunosi, Auvelity |
| Janssen Pharmaceuticals, INC | $64.18 | 2024 | Spravato |
| Lundbeck LLC | $51.48 | 2024 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $27.63 | 2024 | Rexulti |
| Vanda Pharmaceuticals INC. | $16.11 | 2024 | Hetlioz, Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.